News

FHC Partners with Neurotargeting to Offer New Solution for Epilepsy Treatment

• Dec 06, 2019

BOWDOIN, ME – FHC, Inc. and Neurotargeting, LLC have released WayPoint™ Navigator 4.5 planning software, now allowing epileptologists, neurosurgeons,...

News

FHC Announces Comprehensive Epilepsy Solutions for Neurosurgery

BOWDOIN, ME – According to the American Epilepsy Society, at least 30-40% of individuals don’t respond to current antiepileptic...

Event, News

FHC Awarded 2019 People’s Bank Award

• Jun 06, 2019

Last night, FHC was awarded the 2019 People’s United Bank Innovation and Technology Award at the 20th annual Maine...

News

Haer named FHC’s Chairman of the Board

• May 24, 2019

FHC, Inc., a global manufacturer of products for the neuroscience industry, is pleased to announce that F. Andrew (Andy)...

Clinical, Event, News

FHC Announces FDA Clearance for Guideline 5 System

• Mar 15, 2019

BOWDOIN, ME – January 8, 2019 – FHC, Inc., announced today that is has received 510(k) clearance from the...

Clinical, News

FHC products enable use of new surgical technique for Parkinson’s sufferers in Australia

• Mar 14, 2019

Australia’s 9News recently featured a story about a new surgical approach, using FHC products, that is treating Australian patients...

Event, News

FHC Partners to Promote Brain Awareness Week 2019

• Mar 11, 2019

Brain Awareness Week (BAW) 2019 is being celebrated March 11th-17th.  This year, FHC has become a BAW partner, joining...

News, Research

FHC Partners with the University of Kentucky to Explore New Parkinson’s Treatment

• Sep 19, 2018

FHC’s Innovation Center recently collaborated with Dr. Craig Van Horne at the University of Kentucky to explore a new...